Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glufosfamide +/- Hydration in Advanced NSCLC
NCT00005055Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jan 2000
- Primary completion
- Mar 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glufosfamide in non-small cell lung cancer (NSCLC), sponsored by European Organisation for Research and Treatment of Cancer. Started Jan 2000; status: completed.
02
Drugs
glufosfamide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00005055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005055.